Media Center

Press releases

Alfasigma Group Redeploys CARNITENE® (L-carnitine) Business in the Chinese Market

Alfasigma launches diagnostic drug Lumeblue™ ahead of World Digestive Health on 29 May

Alfasigma inaugurates the new Research and Development center in Pomezia named after its founder Marino Golinelli

Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit

Alfasigma acquires Lumeblue™ (Methylene Blue MMX) rights for EU distribution, consolidating its Gastro-Intestinal portfolio

Alfasigma to expand its digital footprint

Press release archive

Multimedia

Social Wall

Press coverage

Alfasigma USA Reintroduces IBS-C Drug Zelnorm to U.S. Market

Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Devel...

Interview with Stefano Golinelli by Margherita Lopes - Adnkronos Salute’s PharmaKronos

Press coverage archive
×

You’re entering Alfasigma global website

I agree